CINECA IRIS Institutional Research Information System

FERRARI, SILVIA MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.996
EU - Europa 4.144
AS - Asia 1.505
AF - Africa 109
SA - Sud America 24
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.747
IT - Italia 1.914
SE - Svezia 829
CN - Cina 783
BG - Bulgaria 520
VN - Vietnam 313
CA - Canada 247
DE - Germania 245
GB - Regno Unito 152
TR - Turchia 146
FI - Finlandia 142
RU - Federazione Russa 108
SG - Singapore 108
UA - Ucraina 92
HK - Hong Kong 58
CI - Costa d'Avorio 57
IN - India 44
BE - Belgio 25
FR - Francia 25
IQ - Iraq 25
SN - Senegal 23
NG - Nigeria 21
PL - Polonia 18
CH - Svizzera 17
NL - Olanda 12
BR - Brasile 9
ES - Italia 9
CZ - Repubblica Ceca 8
IR - Iran 8
RO - Romania 8
AT - Austria 7
JP - Giappone 6
AU - Australia 5
IE - Irlanda 5
CO - Colombia 4
EG - Egitto 4
EU - Europa 4
HU - Ungheria 4
AR - Argentina 3
CL - Cile 3
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
IL - Israele 2
MX - Messico 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
GR - Grecia 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 17.789
Salva come PNG Salva come JPEG
Città #
Fairfield 1.867
Woodbridge 1.525
Houston 1.051
Ashburn 875
Ann Arbor 840
Seattle 808
Chandler 796
Serra 787
Cambridge 683
Wilmington 663
Sofia 520
Milan 445
Beijing 303
New York 301
Princeton 257
Ottawa 231
Lawrence 204
Medford 195
Nanjing 144
Dong Ket 139
Izmir 133
Des Moines 129
Jacksonville 111
San Diego 87
Florence 81
Dearborn 73
Abidjan 57
Hong Kong 54
Boulder 52
Rome 46
Frankfurt am Main 43
Pisa 42
London 39
Nanchang 39
Redwood City 39
Falls Church 35
Kunming 35
Bremen 32
Hebei 32
Norwalk 29
Shenyang 28
Los Angeles 26
Brussels 24
Changsha 24
Dakar 23
Rho 23
Jiaxing 21
Hefei 20
Lagos 20
Sulaymaniyah 20
Washington 20
Pune 19
Boardman 18
Jüchen 18
Ogden 18
Phoenix 17
Tianjin 17
Chicago 16
Massa 16
Guangzhou 15
Carrara 14
San Francisco 14
Warsaw 13
Bern 12
Indiana 12
Lancaster 11
Zhengzhou 11
Auburn Hills 9
Chengdu 9
Jinan 9
Shanghai 9
Sundbyberg 9
Changchun 7
Kent 7
Kilburn 7
Lanzhou 7
Ningbo 7
Nürnberg 7
Amsterdam 6
Detroit 6
Edinburgh 6
São Paulo 6
Vienna 6
Dublin 5
Fremont 5
Grafing 5
Hangzhou 5
Livorno 5
Toronto 5
Wuhan 5
Boston 4
Budapest 4
Dallas 4
Düsseldorf 4
Galati 4
Grosseto 4
Marseille 4
Redmond 4
Sacile 4
Serpukhov 4
Totale 14.504
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 185
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 160
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 156
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 155
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 152
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 146
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 146
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 139
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 138
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 138
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 135
Sorafenib and Thyroid Cancer 130
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 129
Cytokines and HCV-Related Disorders. 127
Sunitinib in the treatment of thyroid cancer 127
Cytokines and HCV-related autoimmune disorders 122
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes 122
Cabozantinib in Thyroid Cancer 121
RET TKI: Potential Role in Thyroid Cancers 120
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 120
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 120
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 118
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 118
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 117
Sorafenib in the treatment of thyroid cancer 117
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 117
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 116
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 116
Aggressive thyroid cancer: targeted therapy with sorafenib 115
New targeted molecular therapies for dedifferentiated thyroid cancer. 114
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 113
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 112
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 111
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 111
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 110
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 110
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation 109
New targeted therapies for anaplastic thyroid cancer. 108
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 108
Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature 108
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 107
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 106
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 105
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 105
null 104
Hepatitis C virus infection - Evidence for an association with type 2 diabetes 104
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 104
The emerging extrahepatic manifestations oh hepatitis C virus infection in chronic hepatitis and mixed cryoglobulinemia. 103
null 103
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 103
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 103
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 103
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis 102
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 102
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study 102
Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. 100
null 100
Autoimmune thyroid disorders 100
Novel treatment options for anaplastic thyroid cancer 100
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 100
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 100
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 100
Dedifferentiated thyroid cancer: a therapeutic challenge 99
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. 99
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 98
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. 98
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 98
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition 98
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. 97
Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease 97
null 97
Selective use of vandetanib in the treatment of thyroid cancer 96
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 96
Prevalence of hypothyroidism and Graves disease in sarcoidosis 95
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis. 95
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 95
Current and future immunotherapies for thyroid cancer 95
The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer 94
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. 93
Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists. 93
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 92
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. 92
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 92
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia. 92
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. 92
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 91
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 91
Novel therapies for thyroid autoimmune diseases: An update 91
Thyroid disorders induced by checkpoint inhibitors 90
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 90
Viral Infections and Type 1 Diabetes 89
Novel Therapies for Thyroid Autoimmune Diseases 89
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied 89
Molecular testing in the diagnosis of differentiated thyroid carcinomas 89
New targeted therapies for thyroid cancer. 88
null 88
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis 88
New Therapies for Dedifferentiated Papillary Thyroid Cancer. 88
null 88
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 88
Totale 10.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.301
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.020 0 0 0 0 0 0 0 0 0 0 545 475
2019/20205.142 475 252 739 264 385 419 536 509 809 332 299 123
2020/20212.057 206 188 265 60 127 60 48 271 105 269 94 364
2021/20222.495 42 116 112 158 412 329 75 163 133 86 166 703
2022/20232.421 361 293 160 194 271 340 46 166 353 11 189 37
2023/20241.852 183 233 257 185 318 385 118 73 35 43 22 0
Totale 18.605